Internacionales

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers. Single stage.

Abierta
Entidad convocante
European Comission
Plazo de presentación
21/04/2022

Type of action: RIA

Single/2 stage: Single stage

Programme budget: 60 M€

Expected EU contribution/ project (M€): ≈ 10 M€

Nº projects expected to be funded: 6

Deadline(s): 21/04/2022

LINK